Radiation recall dermatitis with abemaciclib developing a year after radiotherapy

Radiation recall dermatitis with abemaciclib developing a year after radiotherapy

Importance: Cyclin-dependent kinases 4/6 (CDK4/6) inhibitors had been recently introduced in clinical practice approved for use in hormone receptor (HR) positive/ human epidermal growth factor receptor 2 (HER2) negative advanced or metastatic breast cancer. We report the first incidence of radiation...

Full description

Bibliographic Details
Main Authors: Archya Dasgupta, Francis Patafio, Hany Soliman, Arjun Sahgal, Maureen Trudeau, Gregory J. Czarnota
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Radiation recall dermatitis
Abemaciclib
CDK4/6 inhibito
Radiotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S266662192100003X

Similar Items

Similar Items